Israel - ebraică - Ministry of Health

sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Israel - ebraică - Ministry of Health

j-c health care ltd - abiraterone acetate - טבליה - abiraterone acetate 250 mg - abiraterone - abiraterone - zytiga is cyp 17 inbitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer

Israel - ebraică - Ministry of Health

abbvie biopharmaceuticals ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg / 1 ml - adalimumab

Israel - ebraică - Ministry of Health

novartis israel ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Israel - ebraică - Ministry of Health

neopharm (israel)1996 ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Israel - ebraică - Ministry of Health

amgen europe b.v. - adalimumab - תמיסה להזרקה - adalimumab 50 mg / 1 ml - adalimumab

Israel - ebraică - Ministry of Health

pfizer pharmaceuticals israel ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg / 1 ml - adalimumab

Israel - ebraică - Ministry of Health

samsung bioepis il ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Israel - ebraică - Ministry of Health

dexcel ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Israel - ebraică - Ministry of Health

padagis israel agencies ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg/ml - adalimumab